Home/Filings/4/0001235802-23-000062
4//SEC Filing

Kellen Scott 4

Accession 0001235802-23-000062

CIK 0001401040other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:46 PM ET

Size

6.1 KB

Accession

0001235802-23-000062

Insider Transaction Report

Form 4
Period: 2023-06-01
Kellen Scott
CFO & Secretary
Transactions
  • Award

    Stock Option (right to buy)

    2023-06-01+67,00067,000 total
    Exercise: $2.73Exp: 2033-05-31Common Shares (67,000 underlying)
Holdings
  • Voting Common Shares, no par value per share

    22,290
Footnotes (1)
  • [F1]Vests with respect to 25% of the underlying common shares on June 1, 2024 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2024.

Issuer

DiaMedica Therapeutics Inc.

CIK 0001401040

Entity typeother

Related Parties

1
  • filerCIK 0001490476

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:46 PM ET
Size
6.1 KB